Drugs / RN564
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01293487 | Apr 2011 → May 2012 | disease of bone structure, osteoporosis | Pfizer | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | RN564 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01293487 ↗ |
| Route | Intravenous | “Intravenous, single dose with experimental dose” NCT01293487 ↗ |